Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | Hydrazine hydrate (1:1) | HCID 24654 | — |
| Reactant | HCID 117667475 | HCID 117667475 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 117667080 | HCID 117667080 | 72.3% |
Reaction Steps
A mixture of 5-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzyl]oxy}-6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)pyrazine-2-carboxamide (540 mg), tetrahydrofuran (10.8 mL), ethanol (10.8 mL), and hydrazine monohydrate (160 mg) was stirred at room temperature for 30 hours. The reactant was subjected to liquid separation by the addition of water and chloroform. The organic phase was washed with saturated brine and dried over anhydrous magnesium sulfate, and then the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography (NH2 type: eluent; ethyl acetate, and then chloroform:methanol=97:3) to obtain 5-[(2-aminobenzyl)oxy]-6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)pyrazine-2-carboxamide (315 mg) as a brown solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09085540B2 |
|---|
| Source dataset | uspto-grants-2015_07 |
|---|
| ORD ID | ord-4e858183dea142a7a458de1559416d09 |
|---|
| Source note | uspto-grants-2015_07 |
|---|